We've developed campaigns for more than 200 brands over the past decade. These range from blockbusters with target audiences over 100,000 HCPs to rare diseases with less than 300 targets. While we can't show them all, we've highlighted a few which will give you a good sampling of our work.
Neuroendocrine tumors (NETs), particularly those arising in the gastrointestinal (GI) tract, can produce intermittent, nonspecific symptoms that create a considerable diagnostic challenge. Delayed diagnosis and misdiagnosis are common. In fact, the length of time from initial onset of symptoms to diagnosis of carcinoid syndrome averages 5 to 7 years. Given the diagnostic challenges associated with NETs, a greater index of suspicion is required.
To differentiate the GI symptoms of carcinoid tumors from the diarrhea, abdominal pain, and dyspepsia of irritable bowel syndrome or irritable bowel disease, physicians need to focus on key questions and elicit a patient history that details these nonspecific symptoms.